U.S. Nuclear Medicine Market (2024 - 2030) Size, Share & Trends Analysis Report By Product (Diagnostic (SPECT, PET), Therapeutic (Alpha, Beta Emitters, Brachytherapy)), By Application, By End-use, By Country, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. Application
                        1.2.3. End-use
                        1.2.4. Country scope
                        1.2.5. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in U.S.
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis Models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product
                        2.2.2. Application
                        2.2.3. End-use
                        2.2.4. Country outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Nuclear Medicine Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Rising incidence of cancer and cardiovascular diseases
                            3.2.1.2. Technological advancement in nuclear medicine
                            3.2.1.3. Growing demand for accurate diagnostic & treatment methods
                        3.2.2. Market restraint analysis
                            3.2.2.1. Stringent regulations pertaining to production, storage, and usage nuclear medicines
                            3.2.2.2. High cost associated with diagnostic and therapeutic procedures
                            3.3. U.S. Nuclear Medicine Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
                        3.3.3. Pricing Analysis
                        3.3.4. Pipeline Analysis
                        3.3.5. Procedural Volume Analysis
                            3.3.5.1. Diagnostic Procedures
                                3.3.5.1.1. SPECT
                                3.3.5.1.2. PET
                            3.3.5.2. Therapeutic Procedure
Chapter 4. U.S. Nuclear Medicine Market: Product Estimates & Trend Analysis
                    4.1. U.S. Nuclear Medicine Market: Product Dashboard
                    4.2. U.S. Nuclear Medicine Market: Product Movement Analysis
                    4.3. U.S. Nuclear Medicine Market by Product, Revenue
                    4.4. Diagnostic Products
                        4.4.1. Diagnostic Products market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.2. SPECT
                            4.4.2.1. SPECT market estimates and forecasts 2018 to 2030 (USD Million)
                                4.4.2.1.1. TC-99m
                                4.4.2.1.2. TL-201
                                4.4.2.1.3. GA-67
                                4.4.2.1.4. I-123
                                4.4.2.1.5. Other SPECT Products
                        4.4.3. PET
                            4.4.3.1. PET market estimates and forecasts 2018 to 2030 (USD Million)
                                4.4.3.1.1. F-18
                                4.4.3.1.2. SR-82/RB-82
                                4.4.3.1.3. Other PET products
                    4.5. Therapeutic Products
                        4.5.1. Therapeutic Products market estimates and forecasts 2018 to 2030 (USD Million)
                        4.5.2. Alpha Emitters
                            4.5.2.1. Alpha Emitters market estimates and forecasts 2018 to 2030 (USD Million)
                                4.5.2.1.1. RA-223
                                4.5.2.1.2. Others
                        4.5.3. Beta Emitters
                            4.5.3.1. Beta Emitters market estimates and forecasts 2018 to 2030 (USD Million)
                                4.5.3.1.1. I-131
                                4.5.3.1.2. Y-90
                                4.5.3.1.3. SM-153
                                4.5.3.1.4. Re-186
                                4.5.3.1.5. Lu-117
                                4.5.3.1.6. Other Beta Emitters
                        4.5.4. Brachytherapy
                            4.5.4.1. Brachytherapy market estimates and forecasts 2018 to 2030 (USD Million)
                                4.5.4.1.1. Cesium-131
                                4.5.4.1.2. Iodine-125
                                4.5.4.1.3. Palladium-103
                                4.5.4.1.4. Iridium-192
                                4.5.4.1.5. Other Brachytherapy Products
Chapter 5. U.S. Nuclear Medicine Market: Product Estimates & Trend Analysis
                    5.1. U.S. Nuclear Medicine Market: Product Dashboard
                    5.2. U.S. Nuclear Medicine Market: Product Movement Analysis
                    5.3. U.S. Nuclear Medicine Market by Product (Procedural Volume)
                    5.4. Diagnostic Procedures
                        5.4.1. Diagnostic Procedures market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.2. SPECT
                            5.4.2.1. SPECT market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.3. PET
                            5.4.3.1. PET market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.4. Therapeutic Applications
                            5.4.4.1. Therapeutic applications market estimates and forecasts 2018 to 2030 (USD Million)
                    5.5. Neurology
                        5.5.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
                    5.6. Oncology
                        5.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
                    5.7. Thyroid
                        5.7.1. Thyroid market estimates and forecasts 2018 to 2030 (USD Million)
                        5.7.2. SPECT
                            5.7.2.1. SPECT market estimates and forecasts 2018 to 2030 (USD Million)
                        5.7.3. Therapeutic Applications
                            5.7.3.1. Therapeutic applications market estimates and forecasts 2018 to 2030 (USD Million)
                    5.8. Neurology
                        5.8.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
                    5.9. Oncology
                        5.9.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
                    5.10. Thyroid
                        5.10.1. Thyroid market estimates and forecasts 2018 to 2030 (USD Million)
                            5.10.1.1. SPECT
                            5.10.1.2. SPECT market estimates and forecasts 2018 to 2030 (USD Million)
                            5.10.1.3. Therapeutic Applications
                            5.10.1.4. Therapeutic applications market estimates and forecasts 2018 to 2030 (USD Million)
                    5.11. Lymphoma
                        5.11.1. Lymphoma market estimates and forecasts 2018 to 2030 (USD Million)
                    5.12. Bone Metastasis
                        5.12.1. Bone Metastasis market estimates and forecasts 2018 to 2030 (USD Million)
                            5.12.1.1. SPECT
                            5.12.1.2. SPECT market estimates and forecasts 2018 to 2030 (USD Million)
                            5.12.1.3. Therapeutic Applications
                            5.12.1.4. Therapeutic applications market estimates and forecasts 2018 to 2030 (USD Million)
                    5.13. Endocrine Tumor
                        5.13.1. Endocrine Tumor market estimates and forecasts 2018 to 2030 (USD Million)
                    5.14. Pulmonary Scans
                        5.14.1. Pulmonary Scans market estimates and forecasts 2018 to 2030 (USD Million)
                    5.15. Others
                        5.15.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Nuclear Medicine Market: End-use Estimates & Trend Analysis
                    6.1. U.S. Nuclear Medicine Market: End-use Dashboard
                    6.2. U.S. Nuclear Medicine Market: End-use Movement Analysis
                    6.3. U.S. Nuclear Medicine Market by End-use, Revenue
                    6.4. Hospitals & Clinics
                        6.4.1. Hospitals & Clinics market estimates and forecasts 2018 to 2030 (USD Million)
                    6.5. Diagnostic Centers
                        6.5.1. Diagnostic Centers market estimates and forecasts 2018 to 2030 (USD Million)
                    6.6. Others
                        6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
                            6.6.1.1.
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. List of key distributors and channel partners
                        7.3.2. Key customers
                        7.3.3. Key company market share analysis, 2023
                        7.3.4. Eckert & Ziegler
                            7.3.4.1. Company overview
                            7.3.4.2. Financial performance
                            7.3.4.3. Product benchmarking
                            7.3.4.4. Strategic initiatives
                        7.3.5. Curium
                            7.3.5.1. Company overview
                            7.3.5.2. Financial performance
                            7.3.5.3. Product benchmarking
                            7.3.5.4. Strategic initiatives
                        7.3.6. GE Healthcare
                            7.3.6.1. Company overview
                            7.3.6.2. Financial performance
                            7.3.6.3. Product benchmarking
                            7.3.6.4. Strategic initiatives
                        7.3.7. Jubilant Life Sciences Ltd.
                            7.3.7.1. Company overview
                            7.3.7.2. Financial performance
                            7.3.7.3. Product benchmarking
                            7.3.7.4. Strategic initiatives
                        7.3.8. Bracco Imaging S.P.A
                            7.3.8.1. Company overview
                            7.3.8.2. Financial performance
                            7.3.8.3. Product benchmarking
                            7.3.8.4. Strategic initiatives
                        7.3.9. Nordion (Canada), Inc.
                            7.3.9.1. Company overview
                            7.3.9.2. Financial performance
                            7.3.9.3. Product benchmarking
                            7.3.9.4. Strategic initiatives
                        7.3.10. The Institute For Radioelements (IRE)
                            7.3.10.1. Company overview
                            7.3.10.2. Financial performance
                            7.3.10.3. Product benchmarking
                            7.3.10.4. Strategic initiatives
                        7.3.11. NTP Radioisotopes SOC Ltd.
                            7.3.11.1. Company overview
                            7.3.11.2. Financial performance
                            7.3.11.3. Product benchmarking
                            7.3.11.4. Strategic initiatives
                        7.3.12. Eczacıbaşı-Monrol
                            7.3.12.1. Company overview
                            7.3.12.2. Financial performance
                            7.3.12.3. Product benchmarking
                            7.3.12.4. Strategic initiatives
                        7.3.13. Lantheus Medical Imaging, Inc.
                            7.3.13.1. Company overview
                            7.3.13.2. Financial performance
                            7.3.13.3. Product benchmarking
                            7.3.13.4. Strategic initiatives
                        7.3.14. The Australian Nuclear Science and Technology Organization
                            7.3.14.1. Company overview
                            7.3.14.2. Financial performance
                            7.3.14.3. Product benchmarking
                            7.3.14.4. Strategic initiatives
                        7.3.15. Novartis (Advanced Accelerator Applications)
                            7.3.15.1. Company overview
                            7.3.15.2. Financial performance
                            7.3.15.3. Product benchmarking
                            7.3.15.4. Strategic initiatives
                        7.3.16. Siemens Healthineers AG
                            7.3.16.1. Company overview
                            7.3.16.2. Financial performance
                            7.3.16.3. Product benchmarking
                            7.3.16.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 U.S. Nuclear Medicine Market, 2018 - 2030 (USD Million)
Table 3 U.S. Nuclear Medicine Market, by Product, 2018 - 2030 (USD Million)
Table 4 U.S. Nuclear Medicine Market, by Product (Procedural Volume), 2018 - 2030 (Number of procedures)
Table 5 U.S. Nuclear Medicine Market, by Application, 2018 - 2030 (USD Million)
Table 6 U.S. Nuclear Medicine Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in U.S.
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD Modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. Nuclear Medicine Market: market outlook
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 U.S. Nuclear Medicine Market driver impact
Fig. 13 U.S. Nuclear Medicine Market restraint impact
Fig. 14 U.S. Nuclear Medicine Market: Product movement analysis
Fig. 15 U.S. Nuclear Medicine Market: Product outlook and key takeaways
Fig. 16 Diagnostic Products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 SPECT market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 TC-99m market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 TL-201 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 GA-67 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 I-123 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Other SPECT Products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 PET market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 F-18 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 SR-82/RB-82 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Other PET products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Therapeutic Products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Alpha Emitters market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 RA-223 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Beta Emitters products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 I-131 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Y-90 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 SM-153 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Re-186 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Lu-117 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Other Beta Emitters market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Brachytherapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Cesium-131 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Iodine-125 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Palladium-103 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Iridium-192 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Other Brachytherapy Products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Diagnostic procedures estimate and forecast, 2018 - 2030 (Number of procedures)
Fig. 45 SPECT procedures estimate and forecast, 2018 - 2030 (Number of procedures)
Fig. 46 PET procedures estimate and forecast, 2018 - 2030 (Number of procedures)
Fig. 47 Therapeutic procedures estimate and forecast, 2018 - 2030 (Number of procedures)
Fig. 48 U.S. Nuclear Medicine Market: Application movement analysis
Fig. 49 U.S. Nuclear Medicine Market: Application outlook and key takeaways
Fig. 50 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 SPECT market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 PET market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Therapeutic Applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Thyroid Market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 SPECT market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Therapeutic Applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Lymphoma market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Bone Metastasis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 SPECT market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Therapeutic Applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Endocrine Tumor market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Pulmonary Scans market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 U.S. Nuclear Medicine Market: End-use movement analysis
Fig. 67 U.S. Nuclear Medicine Market: End-use outlook and key takeaways
Fig. 68 Hospitals & Clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Diagnostic Centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 U.S. Nuclear Medicine Market: Country movement analysis
Fig. 72 U.S. Nuclear Medicine Market: Country outlook and key takeaways
Fig. 73 U.S. Nuclear Medicine Market share and leading players
Fig. 74 Market share of key market players- U.S. Nuclear Medicine Market